Renal Artery Stent Market, by Cause Of Renal Stenosis (Atherosclerosis, Fibromuscular dysplasia) and, by End User (Hospitals, Surgical Centers): Global Opportunity Analysis and Industry Forecast, 2023-2032

Renal stents are medical implants that are employed to hold a narrowed artery disease such as atherosclerosis, thereby unblocking the flow of blood to the kidneys. The stents are used as an interventional treatment for renal stenosis. The device is implanted by a minimally invasive procedure that involves the use of guide wire and balloon catheter. Surgeons employ an X-ray-based visualization set up to control the movement and implantation of the stent.

The major factors that drive the growth of the renal stents include increase in renal stenosis cases and increase in ageing population. However, factors such as high costs of renal artery stents are expected to restrain the market growth. Technological advancements and rising popularity of minimally invasive procedures are expected to drive the market growth in future.

The global renal artery stents market is segmented on the cause of renal stenosis, end user, and geography. By cause of renal stenosis, it is classified into atherosclerosis and fibromuscular dysplasia. By end user, the market is divided into hospitals and surgical centers. Geographically, it has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key companies profiled in this report include Abbott Laboratories, Boston Scientific Corporation, C.R. Bard, Cook Medical, Cordis Corporation, Hexacath, Alvimedica Salk Ekipmanlar Pazarlama Sat ve Datm A.., and W.L. Gore & Associates.

Key Benefits

• The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate imminent investment pockets.
• It presents a quantitative analysis to enable stakeholders to capitalize on prevailing market opportunities.
• Extensive analysis of the market by type helps understand regional trends.
• Key players and their strategies have been analyzed to understand the competitive outlook of the market.

  Renal Artery Stent Market, by Cause Of Renal Stenosis Report Highlights

Aspects	Details
By Cause Of Renal Stenosis	Atherosclerosis Fibromuscular dysplasia
By End User	Hospitals Surgical Centers
By Region	North America  (U.S., Canada, Mexico) Europe  (France, Germany, Italy, Spain, UK, Rest of Europe) Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific) LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players	C.R. Bard, Cordis Corporation, W.L. Gore & Associates, Cook Medical, Abbott Laboratories, Boston Scientific Corporation, Alvimedica Salk Ekipmanlar Pazarlama Sat ve Datm A, Hexacath

^*Terms and Conditions Apply